Abstract

Stability of Nebulizer Admixtures

Author(s): Blondino Frank E, Baker Matthew

Issue: Jul/Aug 2005 - Human Hormone Replacement Therapy

Page(s): 323-326

Download in electronic PDF format for $75
  • Stability of Nebulizer Admixtures Page 1
  • Stability of Nebulizer Admixtures Page 2
  • Stability of Nebulizer Admixtures Page 3
  • Stability of Nebulizer Admixtures Page 4

Abstract

There has been an increase in the compounding of admixed respiratory preparations for nebulization. These admixtures may improve patient convenience and compliance, but there are few data regarding the stability of these admixtures. In this study, four drugs from the four major respiratory therapeutic classes were evaluated. Each drug was formulated singularly and in a combination formulation. The physical and chemical stability of each formulation was evaluated under four storage conditions over the course of 8 weeks. The combination formulation was more stable than any of the individual formulations. The formulations stored under elevated temperatures were less stable than those stored at room temperature or in the refrigerator.

Related Keywords

  • respiratory drugs
  • admixtures
  • nebulized drugs
  • beta-agonists
  • corticosteroids
  • mast cell stabilizers
  • anticholinergics
  • stability
  • inhaled preparations

Related Categories

  • PEER-REVIEWED
  • STABILITIES, COMPATIBILITIES
  • RESPIRATION/LUNG/BREATHING

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Jul/Aug 2005
Pg. 323-326
Stability of Nebulizer Admixtures
Author(s): Blondino Frank E, Baker Matthew
May/Jun 2020
Pg. 242-245
Physicochemical Stability and Compatibility of Revefenacin (LAMA) and Formoterol Fumarate (LABA) Inhalation Solution Admixture
Author(s): Ngim Kenley, Patel Jalpa
May/Jun 2013
Pg. 254-261
Physiochemical Compatibility of Nebulizable Drug Admixtures Containing Budesonide and Colistmethate or Hypertonic Saline
Author(s): Klemmer Anja, Krämer Irene, Kamin Wolfgang
Nov/Dec 2020
Pg. 473-478
Intravenous Admixture Preparation Considerations, Part 7: Stability Issues
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 44-50
Intravenous Admixture Preparation Considerations, Part 2: Incompatibilities and Factors Involved
Author(s): Allen Loyd V Jr
May/Jun 2021
Pg. 222-229
Intravenous Admixture Preparation Considerations, Part 9-B: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Mar/Apr 2021
Pg. 131-139
Intravenous Admixture Preparation Considerations, Part 9-A: Error Prevention in Intravenous Admixture Preparation
Author(s): Allen Loyd V Jr
Jan/Feb 2021
Pg. 31-38
Intravenous Admixture Preparation Considerations, Part 8: Ready-to-Use Preparations
Author(s): Allen Loyd V Jr
Jul/Aug 2016
Pg. 328-332
Y-site Physical Compatibility of Beta-blocker Infusions with Intensive Care Unit Admixtures
Author(s): Foushee Jaime A, Meredith Pmichaele, Fox Laura M, Grace EdwardE
Nov/Dec 2019
Pg. 478-482
Intravenous Admixture Preparation Considerations, Part 1: Overview of Series on Personnel Selection for Intravenous Admixture Compounding
Author(s): Allen Loyd V Jr
Sep/Oct 2020
Pg. 397-402
Intravenous Admixture Preparation Considerations, Part 6: pH Considerations -- Applications
Author(s): Allen Loyd V Jr
Sep/Oct 2023
Pg. 397-409
Basics of Sterile Compounding: Sterile Basics of Compounding Intravenous Admixtures, Part 4: Physicochemical Considerations
Author(s): Allen Loyd V Jr
May/Jun 2016
Pg. 202-206
Does Your Drug Expertise Include Clinical Pharmaceutics?
Author(s): Newton David W
Sep/Oct 2007
Pg. 426-432
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion
Author(s): Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A
May/Jun 2022
Pg. 248-254
Physical and Chemical Stability of Pharmaceutical Preparation of Bumetanide and Scopolamine
Author(s): Catry Emilie, Colsoul Marie-Louise, Closset Melanie, Hubert Justine, Soumoy Laura, Bihin Benoit, Thiry Emmanuell, Jamart Jacques, Hecq Jean-Daniel, Galanti Laurence
Jul/Aug 2020
Pg. 305-309
Sterile Basics: Intravenous Admixture Preparation Considerations, Part 5: pH Considerations
Author(s): Allen Loyd V Jr
Jan/Feb 2020
Pg. 30-36
Quality Control: Personal Protective Equipment for Use When Handling Hazardous Drugs
Author(s): Dillon L R
Sep/Oct 2008
Pg. 463-466
Chemical Stability of Admixtures Combining Ziconotide with Fentanyl or Sufentanil During Simulated Intrathecal Administration
Author(s): Shields David E, Aclan Jennifer, Szatkowski Aaron
Jan/Feb 2021
Pg. 73-81
Beyond-use Date of Trimix: A Reproducible Stability Study Using Bracketing Design
Author(s): Patel Gopesh, Davis Countaney, Liu Yi, Ip Kendice, Debideen Krystal E, Anderson Stephanie, Byrne Robert, Herr Dylan, Rhoads Melissa Merrell, Caputo Ross, Banov Daniel, Bassani August S
Jul/Aug 2021
Pg. 311-317
Basics of Sterile Compounding: Intravenous Admixture Preparation Considerations, Part 10: Packaging and Container-closure Issues
Author(s): Allen Loyd V Jr